Kevin Pollack

Kevin Pollack

Director/Board Member chez PRESSURE BIOSCIENCES, INC.

Fortune : 6 441 $ au 31/03/2024

53 ans
Health Technology
Finance
Consumer Services

Profil

Kevin Andrew Pollack is currently the Chairman of Opiant Pharmaceuticals UK Ltd., an Independent Director of Pressure BioSciences, Inc., and the President of Short Hills Capital LLC.
He previously served as the Managing Director of Paragon Capital Advisors LLC (New York) and Paragon Capital LP, CFO, Secretary, Treasurer & Director of Opiant Pharmaceuticals, Inc., and an Independent Director of BBHC, Inc. and Taronis Fuels, Inc. He also served as an Independent Non-Executive Director of BlueNRGY Group Ltd.
In terms of education, he holds a graduate degree and an MBA from Vanderbilt University and an undergraduate degree from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/03/2024 36 787 ( 0,14% ) 6 438 $ 31/03/2024
21/02/2024 21 ( 0,28% ) 4 $ 31/03/2024

Postes actifs de Kevin Pollack

SociétésPosteDébut
PRESSURE BIOSCIENCES, INC. Director/Board Member 03/07/2012
President 01/01/2003
Chairman 01/01/2016
Tous les postes actifs de Kevin Pollack

Anciens postes connus de Kevin Pollack

SociétésPosteFin
TARONIS FUELS, INC. Director/Board Member 08/04/2021
BBHC INC. Director/Board Member 30/09/2020
OPIANT PHARMACEUTICALS, INC. Director of Finance/CFO 01/01/2017
Portfolio Manager-Equities 01/01/2013
Paragon Capital LP Chief Executive Officer 01/01/2013
Voir l'expérience en détail de Kevin Pollack

Formation de Kevin Pollack

Vanderbilt University Graduate Degree
The Wharton School of the University of Pennsylvania Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kevin Pollack

Relations

54

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
PRESSURE BIOSCIENCES, INC.

Health Technology

TARONIS FUELS, INC.

Process Industries

Entreprise privées8

Finance

Finance

Utilities

Health Technology

Industrial Services

Paragon Capital LP

Miscellaneous

Health Technology

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Kevin Pollack